The single greatest operational risk in a home care agency sale is premature disclosure.
When employees find out their agency is for sale before the transaction is complete, the consequences are immediate and severe: key caregivers start seeking other placements, administrators update their résumés, and office staff become distracted and anxious. When referral sources — hospital discharge planners, physicians, or skilled nursing facilities — learn their agency partner is in transition, they may redirect referrals to competitors while the outcome is uncertain. When competitors find out, they may proactively poach your staff or pitch your clients.
The paradox of home care M&A is that the very act of trying to sell your business can destroy the value of what you’re selling — if not managed carefully.
This guide explains how to structure your sale process to protect confidentiality, what the standard NDA process looks like, how to handle the inevitable moment when staff must be told, and how experienced M&A advisors protect their client sellers throughout the process.
Home care is a relationship-intensive business. Unlike an e-commerce business or a software company, where customer relationships are often contractual and less personal, home care depends on:
Caregiver relationships: Caregivers choose where they want to work. News that their agency “might be sold to a big company” creates uncertainty that prompts job searches, even if the reality of post-close changes is minimal.
Referral source relationships: Hospital discharge planners and social workers make daily decisions about which agencies to recommend to patients. Uncertainty about an agency’s ownership or quality creates hesitation.
Client and family relationships: Private pay clients in particular may be concerned about ownership changes affecting their specific caregiver assignments or service quality.
Payer relationships: Medicaid and managed care contracts have ownership change notification requirements. Premature disclosure can trigger administrative complications.
Because these relationships directly drive EBITDA — and EBITDA directly drives purchase price — protecting them during the sale process is not just an operational concern, it’s a financial one.
Who should know about a potential sale?
When you first engage an M&A advisor and begin preparing for a sale, the circle of knowledge should be extremely limited — typically just the owner(s), and perhaps one trusted financial advisor or attorney who needs information to support the process.
At this stage, your M&A advisor will typically need access to your financial statements, organizational charts, and operational data. This information is handled strictly within the advisory firm and not shared externally.
What about your key management team?
This is a judgment call that experienced advisors can help you navigate. There are two schools of thought:
Keep the inner circle tight until a deal is certain: Prevent premature anxiety and ensure confidentiality. The risk: if management finds out from another channel (which sometimes happens), the trust damage is significant.
Read in key management selectively, early: For agencies where one or two key managers are essential to the sale (their ongoing involvement is critical to buyer confidence, or they will need to participate in management presentations), reading them in early with strong confidentiality agreements can be appropriate.
There is no universal right answer — your M&A advisor should help you assess who needs to know and when, based on your specific team dynamics.
The standard process for protecting information shared with potential buyers involves a carefully structured Non-Disclosure Agreement (NDA).
The teaser and blind profile stage
The first materials sent to potential buyers are deliberately non-identifying. A “teaser” or “blind profile” describes your agency’s size, service type, geography at a county or metro level (not city), payer mix, and financial metrics — without revealing the agency’s name, specific location, brand, or any identifying details.
Buyers must express interest and sign an NDA before receiving any identifying information.
Key NDA provisions for home care sales
A home care-specific NDA should include:
Practical tip: NDA enforcement in M&A practice is rare but real. Most PE firms and strategic buyers in the home care market take NDA obligations seriously — partly because reputation risk in a networked industry is significant. However, having a well-drafted NDA gives you meaningful protection and recourse if a buyer violates it.
Once a buyer signs the NDA and receives the Confidential Information Memorandum (CIM), they have access to detailed financial, operational, and organizational information — but still through a controlled process.
Virtual data room management
Professional M&A advisors use virtual data room (VDR) technology (platforms like Firmex, Intralinks, or Datasite) to share confidential documents with qualified buyers. The VDR offers:
What to include — and what to withhold
Not all buyer requests should be fulfilled at every stage. As a general principle:
Work with your M&A advisor to define a disclosure schedule that balances buyer due diligence needs against your operational protection interests.
Management presentations — usually held after the LOI stage or late in the process for a select group of serious buyers — represent the moment when your key managers may need to be told about the transaction for the first time.
Reading in your management team
If management presentations require the participation of your Administrator, Director of Nursing, or other senior staff, those individuals will need to be read in before the meetings. Best practices:
Manage the emotional dimension. Key staff members who are told about a sale may have genuine concerns about their future. How you handle this conversation — the honesty, care, and respect you demonstrate — directly affects whether they stay engaged and professional through the process.
The period between a signed LOI and final closing is typically 60–120 days. It is the most prolonged period during which the transaction is active, and therefore the longest window of confidentiality risk.
During this phase:
Maintaining operational normalcy is the most important discipline during this period. Sellers who change operational behavior — slowing hiring, cutting marketing, deferring decisions — create visible signals that something is happening, which can cascade into rumors.
Continue to run the business as if there is no transaction. Continue hiring, managing, developing referral relationships, and investing appropriately.
When the transaction closes, you will need to communicate the ownership change to:
Best practice: Prepare communication materials with your advisor and the buyer before closing. Many transactions include a joint announcement strategy — a letter from both the outgoing and incoming ownership expressing confidence in the transition and reassuring clients and referral partners of continuity.
Timing is critical: announcements should go out as close to closing as possible to prevent leaks from the inevitable spread of information once more people are involved.
Working with a specialized M&A advisor rather than running a sale process yourself provides significant structural confidentiality advantages:
Discuss a confidential sale process with Hendon Partners →
At Hendon Partners, confidentiality management is central to how we run every home care sale process. We use institutional data room technology, carefully drafted NDAs, and a process structure specifically designed to protect our clients’ businesses from the risks of premature disclosure.
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.
